Company intelligence / Profile preview

VitaCosmoX

Ownership: Private
Development stage: Other

Overview

VitaCosmoX is a biotechnology and consumer health company focused on the development of advanced longevity solutions and cellular rejuvenation therapies. The company specializes in the formulation of high-bioavailability supplements and topical treatments designed to enhance mitochondrial function and activate sirtuin pathways. By bridging the gap between pharmaceutical-grade research and consumer wellness, VitaCosmoX provides products aimed at slowing the biological aging process and improving metabolic health. Their current portfolio includes proprietary blends of NAD+ precursors and antioxidant peptides marketed to health-conscious consumers and longevity clinics.

Therapeutic areas: NeurologyOtherMetabolic Disorders
Modalities: Small moleculePeptidesNutraceuticals
Industry: Food & Nutrition

Beyond the preview

Go deeper on VitaCosmoX.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on VitaCosmoX.

Explore the full profile